NPTX2 and cognitive dysfunction in Alzheimer’s Disease
Open accessAbstract
Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and loss of synapses. Here, we present findings supporting a special role for excitatory synapses connecting pyramidal neurons of the hippocampus and cortex with fast-spiking parvalbumin (PV) interneurons that control network excitability and rhythmicity. Excitatory synapses on PV interneurons are dependent on the AMPA receptor subunit GluA4, which is regulated by presynaptic expression of the synaptogenic immediate early gene NPTX2 by pyramidal neurons. In a mouse model of AD amyloidosis, Nptx2-/- results in reduced GluA4 expression, disrupted rhythmicity, and increased pyramidal neuron excitability. Postmortem human AD cortex shows profound reductions of NPTX2 and coordinate reductions of GluA4. NPTX2 in human CSF is reduced in subjects with AD and shows robust correlations with cognitive performance and hippocampal volume. These findings implicate failure of adaptive control of pyramidal neuron-PV circuits as a pathophysiological mechanism contributing to cognitive failure in AD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NPTXs might be a selective marker for the imbalance of pyramidal neuron-interneuron microcircuits thought to underlie cognitive impairment in Alzheimer's disease.
“NPTXs might be a selective marker for the imbalance of pyramidal neuron-interneuron microcircuits, thought to underlie cognitive impairment in AD (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
Deregulation of neuronal activity could explain changes in NPTXs and drive neurodegenerative processes.
“Deregulation of neuronal activity could explain changes in NPTXs and drive neurogenerative processes (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
ROC analysis concluded a similar test performance to distinguish AD from controls than that of the classical AD biomarkers.
“The receiver operating characteristic (ROC) analysis concluded a similar test performance to distinguish AD from controls than that of the classical AD biomarkers (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
GluA4 was reduced in the precuneus and medial frontal gyri and correlated with NPTX2 in both control and AD group.
“The subunit of AMPAR, GluA4, was also reduced in this study (both in the precuneus and medial frontal gyri) and correlated with NPTX2 in both control and AD group (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
CSF NPTXR levels, both the full length protein and the peptides resulting from TACE cleavage, were reduced in AD in comparison with controls.
“CSF NPTXR levels, both the full length protein and the peptides resulting from TACE cleavage, were reduced in AD in comparison with controls (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX2 correlates with medial temporal atrophy, hippocampal volume and cognitive impairment.
“This was further sustained by studies that found NPTX2 correlating with medial temporal atrophy, hippocampal volume and cognitive impairment (Nilsson et al. 2021; Swanson et al. 2016; Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
The reduction of NPTX2 could be linked to the disruption of the pyramidal neuron-PV interneuron microcircuit, contributing to cognitive failure in AD.
“Consequently, the reduction of NPTX2 could be linked to the disruption of pyramidal neuron-PV interneuron microcircuit, contributing to cognitive failure in AD (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX2 was decreased in post-mortem cortex from AD patients (hippocampus not analysed).
“NPTX2 was also decreased in post-mortem cortex from AD patients (hippocampus not analysed) (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX2 exhibits a weak correlation with p-tau181 and total tau.
“NPTX2 exhibited a weak correlation with p-tau181 and total tau (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX1 and NPTXR do not correlate with Aβ42.
“NPTX1 and NPTXR did not correlate with Aβ42, but did weakly correlate with total tau and p-tau181 (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX1 and NPTXR weakly correlate with total tau and p-tau181.
“NPTX1 and NPTXR did not correlate with Aβ42, but did weakly correlate with total tau and p-tau181 (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
CSF levels of different NPTXs strongly correlate with each other in both AD and genetic FTLD.
“Finally, CSF levels of the different NPTXs strongly correlated with each other in both AD and genetic FTLD, indicating an overall reduction of these proteins in CSF (Nilsson et al. 2021; van der Ende et al. 2020; Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTX2 does not correlate with Aβ42.
“Some authors described a weak correlation with Aβ42, mainly in MCI (Galasko et al. 2019; Nilsson et al. 2021), whereas others found no correlation (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTXs may contribute to cognitive decline in neurodegeneration and other diseases of the CNS by modifying excitatory synaptic drive onto fast-spiking PV interneurons, leading to E/I imbalance.
“NPTXs may contribute to the cognitive decline in neurodegeneration and other diseases of the CNS by modifying the excitatory synaptic drive onto fast-spiking PV interneurons which leads to E/I imbalance.”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTXs might be a good candidate biomarker for disease staging and cognitive prognosis.
“Thus, they might be a good candidate biomarker for disease staging and cognitive prognosis (Galasko et al. 2019; Libiger et al. 2021; Nilsson et al. 2021; Swanson et al. 2016; Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
This E/I imbalance might promote or accelerate disease progression by increasing demand in other compensatory mechanisms.
“This might promote or accelerate disease progression by increasing the demand in other compensatory mechanisms (Hu et al. 2010; Shepherd et al. 2006; Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
NPTXs show an added role when combined with core AD biomarkers in predicting progression from MCI to AD dementia and in discriminating AD and healthy controls, e.g., NPTX2 in ratio with either total tau or p-tau.
“NPTXs also showed an added role when combined with core AD biomarkers in predicting the progression from MCI to AD dementia and in discriminating AD and healthy controls, e.g., NPTX2 in ratio with either total tau or p-tau (Galasko et al. 2019; Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
CSF NPTX levels correlate with cognitive scores in AD patients, even in the absence of brain pathology.
“Unlike core biomarkers such as Aβ (Williams et al. 2011), CSF NPTXs levels correlated with cognitive scores in AD patients, even in the absence of brain pathology.”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
In the pre-symptomatic stage, NPTXs may act as a resilience factor keeping the integrity of synapses.
“In the pre-symptomatic stage, NPTXs may act as a resilience factor keeping the integrity of the synapses, as previously hypothesised (Xiao et al. 2017).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Xiao et al. 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,803 · see citing works
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,003 · see citing works
<i>The Brain's Default Network</i>: <i>Anatomy, Function, and Relevance to Disease</i>
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761 · see citing works
Basic principles of ROC analysis
Metz, C. E. (1978) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(78)80014-2 · Cited by 6,058 · see citing works
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · see citing works
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378 · see citing works
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347 · see citing works
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · see citing works
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · see citing works
Dynamic predictions: Oscillations and synchrony in top–down processing
Engel, A. K., Fries, P., & Singer, W. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094565 · Cited by 3,454 · see citing works
The assessment of aphasia and related disorders
Goodglass, H., & Kaplan, E. (1972) · Medical Entomology and Zoology · Cited by 3,258 · see citing works
A Standardized Memory Scale for Clinical Use
Wechsler, D. (1945) · The Journal of Psychology · doi:10.1080/00223980.1945.9917223 · Cited by 2,960 · see citing works
Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862 · see citing works
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796 · see citing works
A Modified Card Sorting Test Sensitive to Frontal Lobe Defects
Nelson, H. E. (1976) · Cortex · doi:10.1016/s0010-9452(76)80035-4 · Cited by 2,454 · see citing works
Assessment of Aphasia and Related Disorders
Sarno, M. T. (1973) · Physical Therapy · doi:10.1093/ptj/53.2.225b · Cited by 2,256 · see citing works
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · see citing works
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · see citing works
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · see citing works
WAIS-R manual : Wechsler adult intelligence scale-revised
Wechsler, D. (1981) · Medical Entomology and Zoology · Cited by 1,575 · see citing works
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Toga, A. W., & Beckett, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,493 · see citing works
California Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (1987) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,450 · see citing works
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works
Borkowski, J. G., Benton, A. L., & Spreen, O. (1967) · Neuropsychologia · doi:10.1016/0028-3932(67)90015-2 · Cited by 1,324 · see citing works
Geiger, J. R. P., Melcher, T., Koh, D.-S., Sakmann, B., Seeburg, P. H., Jonas, P., & Monyer, H. (1995) · Neuron · doi:10.1016/0896-6273(95)90076-4 · Cited by 1,260 · see citing works
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216 · see citing works
Homeostatic Synaptic Plasticity: Local and Global Mechanisms for Stabilizing Neuronal Function
Turrigiano, G. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005736 · Cited by 1,139 · cited 1× · see citing works
“This adaptive strengthening of the pyramidal neuron-PV interneuron synapse mediates homeostatic scaling of the circuit, a process implicated in the ability of circuits to encode information (Turrigiano, 2012).”
BackgroundEnvironment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles
Guzowski, J. F., McNaughton, B. L., Barnes, C. A., & Worley, P. F. (1999) · Nature Neuroscience · doi:10.1038/16046 · Cited by 1,035 · see citing works
Self-citationSperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027 · see citing works
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works
Biomarker Modeling of Alzheimer’s Disease
Jack, C. R., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.12.003 · Cited by 1,002 · see citing works
Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat
Csicsvari, J., Hirase, H., Czurkó, A., Mamiya, A., & Buzsáki, G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00274.1999 · Cited by 966 · see citing works
Coherent spontaneous activity identifies a hippocampal-parietal memory network
Vincent, J. L., Snyder, A. Z., Fox, M. D., Shannon, B. J., Andrews, J. R., Raichle, M. E., & Buckner, R. L. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00048.2006 · Cited by 959 · cited 2× · see citing works
“(Buckner et al., 2008; Greicius et al., 2004; Vincent et al., 2006) and is notable for high levels of amyloid detected by PET in AD subjects and some aged control individuals (Sperling et al.”
BackgroundInfluentialCholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro
Fisahn, A., Pike, F. G., Buhl, E. H., & Paulsen, O. (1998) · Nature · doi:10.1038/28179 · Cited by 884 · see citing works
Arc/Arg3.1 Mediates Homeostatic Synaptic Scaling of AMPA Receptors
Shepherd, J. D., Rumbaugh, G., Wu, J., Chowdhury, S., Plath, N., Kuhl, D., Huganir, R. L., & Worley, P. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.034 · Cited by 779 · see citing works
Self-citationEpisodic and Semantic Memory: A Comparison of Amnesic and Demented Patients
Butters, N., Granholm, E. L., Salmon, D. P., Grant, I., & Wolfe, J. (1987) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638708410764 · Cited by 596 · see citing works
Self-citationUm, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572 · see citing works
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Reed, I. K. G., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 562 · see citing works
Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease
Rouleau, I., Salmon, D. P., Butters, N., Kennedy, C. M., & McGuire, K. (1992) · Brain and Cognition · doi:10.1016/0278-2626(92)90112-y · Cited by 556 · see citing works
Self-citationFuchs, E. C., Zivkovic, A. R., Cunningham, M. O., Middleton, S., LeBeau, F. E. N., Bannerman, D. M., Rozov, A., Whittington, M. A., Traub, R. D., Rawlins, J. N. P., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.031 · Cited by 532 · see citing works
Detection and Staging of Dementia in Alzheimer's Disease
Welsh-Bohmer, K. A. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290030008 · Cited by 473 · see citing works
Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.
O’Brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., & Worley, P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80782-5 · Cited by 471 · see citing works
Self-citationWeiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348 · see citing works
Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C. J., Cameron, J. L., Hruban, R. H., & Goggins, M. (2003) · PubMed · Cited by 328 · see citing works
Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons
Chang, M. C., Park, J. M., Pelkey, K. A., Grabenstatter, H. L., Xu, D., Linden, D. J., Sutula, T. P., McBain, C. J., & Worley, P. F. (2010) · Nature Neuroscience · doi:10.1038/nn.2621 · Cited by 316 · see citing works
Self-citationTsui, C., Copeland, N., Gilbert, D., Jenkins, N., Barnes, C., & Worley, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02463.1996 · Cited by 315 · see citing works
Self-citationVazdarjanova, A. I., McNaughton, B. L., Barnes, C. A., Worley, P. F., & Guzowski, J. F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10067.2002 · Cited by 307 · see citing works
Self-citationAlzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 279 · see citing works
Xu, D., Hopf, C., Reddy, R., Cho, R. W., Guo, L., Lanahan, A., Petralia, R. S., Wenthold, R. J., O'Brien, R. J., & Worley, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00463-x · Cited by 265 · see citing works
Self-citationHomeostatic Scaling Requires Group I mGluR Activation Mediated by Homer1a
Hu, J.-H., Park, J. M., Park, S. J., Xiao, B., Dehoff, M. H., Kim, S., Hayashi, T., Schwarz, M. K., Huganir, R. L., Seeburg, P. H., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.008 · Cited by 263 · see citing works
Self-citationPelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.020 · Cited by 245 · see citing works
Self-citationSannerud, R., Declerck, I., Peric, A., Raemaekers, T., Menéndez, G., Zhou, L., Baert, V., Coen, K., Munck, S., Strooper, B. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100745108 · Cited by 239 · see citing works
Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent β-Amyloid Generation
Wu, J., Petralia, R. S., Kurushima, H., Patel, H., Jung, M., Volk, L. J., Chowdhury, S., Shepherd, J. D., Dehoff, M. H., Li, Y., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.036 · Cited by 215 · see citing works
Self-citationFjell, A. M., Walhovd, K. B., Fennema‐Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., Brewer, J. B., Dale, A. M., & Initiative, A. D. N. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3785-09.2010 · Cited by 209 · see citing works
Self-citationComery, T., Martone, R., Aschmies, S., Atchison, K., Diamantidis, G., Gong, X.-H., Zhou, H., Kreft, A., Pangalos, M., Sonnenberg-Reines, J., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2693-05.2005 · Cited by 204 · see citing works
Sia, G.-M., Béïque, J.-C., Rumbaugh, G., Cho, R., Worley, P. F., & Huganir, R. L. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.020 · Cited by 201 · see citing works
Self-citationPredicting MCI outcome with clinically available MRI and CSF biomarkers
Heister, D. S., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, A. D. N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343314 · Cited by 201 · see citing works
Self-citationReporting standards for studies of diagnostic test accuracy in dementia
Noel-Storr, A. H., McCleery, J. M., Richard, E., Ritchie, C. W., Flicker, L. A., Cullum, S. J., Davis, D. H. J., Quinn, T. J., Hyde, C., Rutjes, A. W., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000621 · Cited by 194 · see citing works
A review of gamma oscillations in healthy subjects and in cognitive impairment
Başar, E. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2013.07.005 · Cited by 190 · see citing works
Brewer, J. B., Magda, S., Airriess, C. N., & Smith, M. E. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1402 · Cited by 173 · see citing works
Self-citationO'Brien, R., Xu, D., Mi, R., Tang, X., Hopf, C., & Worley, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04487.2002 · Cited by 160 · see citing works
Self-citationTrafficking regulation of proteins in Alzheimer’s disease
Jiang, S., Li, Y., Zhang, X., Bu, G.-J., Xu, H.-X., & Zhang, Y.-W. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-6 · Cited by 153 · see citing works
Hirata, H., Ueno, K., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055502 · Cited by 147 · see citing works
Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses
Lee, S.-J., Wei, M., Zhang, C., Maxeiner, S., Pak, C., Calado Botelho, S., Trotter, J., Sterky, F. H., & Südhof, T. C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2768-16.2016 · Cited by 146 · see citing works
Priming of hippocampal population bursts by individual perisomatic-targeting interneurons
Ellender, T., Nissen, W., Colgin, L., Mann, E., & Paulsen, O. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3962-09.2010 · Cited by 142 · see citing works
Kimura, R., Devi, L., & Ohno, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06608.x · Cited by 139 · see citing works
Angulo, M. C., Lambolez, B., Audinat, É., Hestrin, S., & Rossier, J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-17-06685.1997 · Cited by 136 · see citing works
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly
Driscoll, I., Resnick, S. M., Troncoso, J. C., An, Y., O'Brien, R., & Zonderman, A. B. (2006) · Annals of Neurology · doi:10.1002/ana.21031 · Cited by 132 · see citing works
Self-citationAsymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
Driscoll, I., & Troncoso, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745348 · Cited by 130 · see citing works
Self-citationFunctional Connectivity in Autosomal Dominant and Late-Onset Alzheimer Disease
Thomas, J. B., Brier, M. R., Bateman, R. J., Snyder, A. Z., Benzinger, T. L., Xiong, C., Raichle, M., Holtzman, D. M., Sperling, R. A., Mayeux, R., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1654 · Cited by 129 · see citing works
Cho, R. W., Park, J. M., Wolff, S. B. E., Xu, D., Hopf, C., Kim, J.-A., Reddy, R. C., Petralia, R. S., Perin, M. S., Linden, D. J., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.010 · Cited by 125 · see citing works
Self-citationHuang, Y. A., Ruiz, C. R., Eyler, E. C. H., Lin, K., & Meffert, M. K. (2012) · Cell · doi:10.1016/j.cell.2012.01.036 · Cited by 122 · see citing works
Mikuni, T., Uesaka, N., Okuno, H., Hirai, H., Deisseroth, K. A., Bito, H., & Kano, M. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.036 · Cited by 120 · see citing works
Obligatory Role for the Immediate Early Gene NARP in Critical Period Plasticity
Gu, Y., Huang, S., Chang, M., Worley, P. F., Kirkwood, A., & Quinlan, E. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.016 · Cited by 117 · see citing works
Self-citationChiang, C.-P., Hou, M., & Hung, W. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.009 · Cited by 117 · see citing works
miR-96 regulates the progression of differentiation in mammalian cochlear inner and outer hair cells
Kuhn, S., Johnson, S. L., Furness, D. N., Chen, J., Ingham, N., Hilton, J. M., Steffes, G., Lewis, M. A., Zampini, V., Hackney, C. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016646108 · Cited by 114 · see citing works
Demanuele, C., James, C. J., & Sonuga-Barke, E. J. S. (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-62 · Cited by 91 · see citing works
Swanson, A., & Willette, A. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.148 · Cited by 79 · see citing works
Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells
Xu, D., He, X., Chang, Y., Xu, C., Jiang, X. W., Sun, S., & Lin, J. (2012) · Oncology Reports · doi:10.3892/or.2012.2138 · Cited by 71 · see citing works
Self-citationNelson, P. T., Abner, E. L., Scheff, S. W., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Smith, C. D., Patel, E., & Markesbery, W. R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.006 · Cited by 70 · see citing works
Townsend, M., Qu, Y., Gray, A. J., Wu, Z., Seto, T., Hutton, M., Shearman, M. S., & Middleton, R. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163691 · Cited by 42 · see citing works
Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern
Jensen, K. P., & Covault, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq798 · Cited by 38 · see citing works
Pelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.024 · Cited by 22 · see citing works
Self-citationZhang, L., Gao, J., Li, Z., & Gong, Y.-F. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2202-8 · Cited by 21 · see citing works
Longitudinal brain activity changes in asymptomatic Alzheimer disease
Codispoti, K.-E., Beason‐Held, L. L., Kraut, M. A., O’Brien, R., Rudow, G. L., Pletniková, O., Crain, B. J., Troncoso, J. C., & Resnick, S. M. (2012) · Brain and Behavior · doi:10.1002/brb3.47 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0143-7 · Cited by 964 · see citing works
Self-citationLópez, J. A., González, H. M., & Léger, G. C. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 834 · see citing works
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 632 · see citing works
“(F) Consistent protein changes of 8 proteins in AD brain tissue and CSF.”
BackgroundInfluentialSynaptic degeneration in Alzheimer disease
Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504 · see citing works
Mathys, H., Peng, Z., Boix, C. A., Victor, M. B., Leary, N., Babu, S., Abdelhady, G., Jiang, X., Ng, A. P., Ghafari, K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.039 · Cited by 495 · see citing works
Higginbotham, L., Ping, L., Dammer, E. B., Duong, D. M., Zhou, M., Gearing, M., Hurst, C., Glass, J. D., Factor, S. A., Johnson, E. C. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz9360 · Cited by 367 · see citing works
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00474-z · Cited by 252 · see citing works
Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model
Etter, G., van der Veldt, S., Manseau, F., Zarrinkoub, I., Trillaud-Doppia, É., & Williams, S. (2019) · Nature Communications · doi:10.1038/s41467-019-13260-9 · Cited by 242 · see citing works
Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., & Schwartz, J. B. (2018) · The FASEB Journal · doi:10.1096/fj.201700731r · Cited by 219 · see citing works
Turk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 206 · see citing works
Farhy-Tselnicker, I., van Casteren, A. C. M., Lee, A., Chang, V. T., Aricescu, A. R., & Allen, N. J. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.053 · Cited by 199 · see citing works
Fluid Biomarkers for Synaptic Dysfunction and Loss
Camporesi, E., Nilsson, J., Brinkmalm, A., Becker, B., Ashton, N. J., Blennow, K., & Zetterberg, H. (2020) · Biomarker Insights · doi:10.1177/1177271920950319 · Cited by 165 · see citing works
Shaping Synapses by the Neural Extracellular Matrix
Ferrer-Ferrer, M., & Dityatev, A. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00040 · Cited by 169 · see citing works
Immediate and deferred epigenomic signatures of in vivo neuronal activation in mouse hippocampus
Fernandez-Albert, J., Lipinski, M., Lopez-Cascales, M. T., Rowley, M. J., Martin-Gonzalez, A. M., del Blanco, B., Corces, V. G., & Barco, A. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0476-2 · Cited by 166 · see citing works
Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents
Tappe‐Theodor, A., King, T. E., & Morgan, M. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.009 · Cited by 165 · see citing works
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 168 · see citing works
Stimulus-dependent representational drift in primary visual cortex
Marks, T. D., & Goard, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-25436-3 · Cited by 175 · see citing works
The visual word form area (VWFA) is part of both language and attention circuitry
Chen, L., Wassermann, D., Abrams, D. A., Kochalka, J., Gallardo, G., & Menon, V. (2019) · Nature Communications · doi:10.1038/s41467-019-13634-z · Cited by 150 · see citing works
Zhou, J., Wade, S. D., Graykowski, D., Xiao, M.-F., Zhao, B., Giannini, L. A. A., Hanson, J. E., van Swieten, J. C., Sheng, M., Worley, P. F., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf0141 · Cited by 152 · see citing works
Self-citationConnolly, K., Lehoux, M., O’Rourke, R., Assetta, B., Erdemir, G. A., Elias, J. A., Lee, C. G., & Huang, Y. A. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12612 · Cited by 142 · see citing works
Fast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer’s disease
Hijazi, S., Smit, A. B., & van Kesteren, R. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02168-y · Cited by 144 · see citing works
Galasko, D., Xiao, M., Xu, D., Smirnov, D., Salmon, D. P., Dewit, N., Vanbrabant, J., Jacobs, D., Vanderstichele, H., Vanmechelen, E., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.11.002 · Cited by 133 · see citing works
Self-citationLongitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
Libiger, O., Shaw, L. M., Watson, M. H., Nairn, A. C., Umaña, K. L., Biarnes, M. C., Canet‐Avilés, R. M., Jack, C. R., Breton, Y., Cortes, L., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12353 · Cited by 108 · see citing works
Sathe, G., Na, C. H., Renuse, S., Madugundu, A. K., Albert, M., Moghekar, A., & Pandey, A. (2019) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201800105 · Cited by 126 · see citing works
Input–output organization of the mouse claustrum
Zingg, B., Dong, H., Tao, H. W., & Zhang, L. I. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24502 · Cited by 126 · see citing works
The functional organization of cortical feedback inputs to primary visual cortex
Marques, T., Nguyen, J. K., Fioreze, G. T., & Petreanu, L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0135-z · Cited by 117 · see citing works
Mozafari, M., Ganjtabesh, ., Nowzari-Dalini, A., & Masquelier, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00625 · Cited by 125 · see citing works
Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making
Bang, D., Kishida, K. T., Lohrenz, T. M., White, J. P., Laxton, A. W., Tatter, S. B., Fleming, S. M., & Montague, P. R. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.015 · Cited by 123 · see citing works
Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance
Varela, E. V., Etter, G., & Williams, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.010 · Cited by 116 · see citing works
Mossink, B., Negwer, M., Schubert, D., & Nadif Kasri, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03714-5 · Cited by 114 · see citing works
Gómez de San José, N., Massa, F., Halbgebauer, S., Oeckl, P., Steinacker, P., & Otto, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02411-2 · Cited by 112 · see citing works
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
Simrén, J., Ashton, N. J., Blennow, K., & Zetterberg, H. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.019 · Cited by 100 · see citing works
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Soldan, A., Pettigrew, C. A., Fagan, A. M., Schindler, S. E., Moghekar, A., Fowler, C. J., Li, Q.-X., Collins, S. J., Carlsson, C. M., Asthana, S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007248 · Cited by 104 · see citing works
N-myristoylation: from cell biology to translational medicine
Meng, Y. G., Song, Z., Ying, M., Zhu, H., He, Q., Yang, B., & Cao, J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0388-4 · Cited by 101 · see citing works
Krishnaswamy, V. R., Benbenishty, A., Blinder, P., & Sagi, I. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03182-6 · Cited by 92 · see citing works
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
van der Ende, E. L., Xiao, M., Xu, D., Poos, J. M., Panman, J. L., Jiskoot, L. C., Meeter, L. H., Dopper, E. G., Papma, J. M., Heller, C., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322493 · Cited by 94 · see citing works
Self-citationCurrent advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
Leuzy, A., Cullen, N. C., Mattsson, N., & Hansson, O. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000904 · Cited by 87 · see citing works
Delling, J. P., & Boeckers, T. M. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09397-8 · Cited by 96 · see citing works
Chen, J., Zhao, X., Cui, L., He, G., Wang, X., Wang, F., Duan, S., He, L., Li, Q., Yu, X., et al. (2020) · Aging · doi:10.18632/aging.103150 · Cited by 91 · see citing works
Caccavano, A., Bozzelli, P. L., Forcelli, P. A., Pak, D. T. S., Wu, J., Conant, K. E., & Vicini, S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0425-20.2020 · Cited by 85 · see citing works
Vermeiren, S., Bellefroid, E., & Desiderio, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.587699 · Cited by 87 · see citing works
Fermie, J., Liv, N., ten Brink, C., van Donselaar, E. G., Müller, W. H., Schieber, N. L., Schwab, Y., Gerritsen, H. C., & Klumperman, J. (2018) · Traffic · doi:10.1111/tra.12557 · Cited by 86 · see citing works
Panchal, V. V., Griffiths, C., Mosaei, H., Bilyk, B. L., Sutton, J. A. F., Carnell, O. T., HORNBY, D. P., Green, J. D., Hobbs, J. K., Kelley, W. L., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008672 · Cited by 85 · see citing works
van Steenoven, I., Koel-Simmelink, M. J. A., Vergouw, L. J. M., Tijms, B. M., Piersma, S. R., Pham, T. V., Bridel, C., Ferri, G.-L., Cocco, C., Noli, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00388-2 · Cited by 83 · see citing works
Self-citationMitofusins: Disease Gatekeepers and Hubs in Mitochondrial Quality Control by E3 Ligases
Escobar‐Henriques, M., & Joaquim, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00517 · Cited by 81 · see citing works
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Nilsson, J., Gobom, J., Sjödin, S., Brinkmalm, G., Ashton, N. J., Svensson, J., Johansson, P., Portelius, E., Zetterberg, H., Blennow, K., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12179 · Cited by 82 · see citing works
Nilsson, J., Binette, A. P., Palmqvist, S., Brum, W. S., Janelidze, S., Ashton, N. J., Spotorno, N., Stomrud, E., Gobom, J., Zetterberg, H., et al. (2024) · Brain · doi:10.1093/brain/awae032 · Cited by 82 · see citing works
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works
Arroyo‐García, L. E., Isla, A. G., Andrade‐Talavera, Y., Balleza‐Tapia, H., Loera‐Valencia, R., Alvarez-Jimenez, L., Pizzirusso, G., Tambaro, S., Nilsson, P., & Fisahn, A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01257-0 · Cited by 74 · see citing works
Aryal, S., Bonanno, K., Song, B. J., Mani, D. R., Keshishian, H., Carr, S. A., Sheng, M., & Dejanovic, B. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112497 · Cited by 74 · see citing works
14-3-3 modulation of the inflammatory response
Munier, C. C., Ottmann, C., & Perry, M. W. D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105236 · Cited by 73 · see citing works
Hippocampal network oscillations at the interplay between innate anxiety and learned fear
Çalışkan, G., & Stork, O. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5109-z · Cited by 72 · see citing works
Neuroinflammation in Alzheimer’s disease: Pleiotropic roles for cytokines and neuronal pentraxins
Swanson, A., Wolf, T., Sitzmann, A., & Willette, A. A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.015 · Cited by 72 · see citing works
Kluever, V., Russo, B., Mandad, S., Kumar, N. H., Alevra, M., Ori, A., Rizzoli, S. O., Urlaub, H., Schneider, A., & Fornasiero, E. F. (2022) · Science Advances · doi:10.1126/sciadv.abn4437 · Cited by 69 · see citing works
Burghardt, L. T. (2019) · New Phytologist · doi:10.1111/nph.16045 · Cited by 70 · see citing works
Eat, sleep, repeat – endocrine regulation of behavioural circadian rhythms
Koop, S., & Oster, H. (2021) · FEBS Journal · doi:10.1111/febs.16109 · Cited by 68 · see citing works
Novel <scp>CSF</scp> biomarkers in genetic frontotemporal dementia identified by proteomics
van der Ende, E. L., Meeter, L. H., Stingl, C., van Rooij, J. G. J., Stoop, M. P., Nijholt, D. A. T., Sanchez‐Valle, R., Graff, C., Öijerstedt, L., Grossman, M., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.745 · Cited by 65 · see citing works
Modeste, E. S., Ping, L., Watson, C. M., Duong, D. M., Dammer, E. B., Johnson, E. C. B., Roberts, B. R., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00638-z · Cited by 62 · see citing works
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease
Sathe, G. J., Albert, M., Darrow, J. A., Saito, A., Troncoso, J. C., Pandey, A., & Moghekar, A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15116 · Cited by 65 · see citing works
Self-citationHaque, R., Watson, C. M., Liu, J., Carter, E. K., Duong, D. M., Lah, J. J., Wingo, A. P., Roberts, B. R., Johnson, E. C. B., Saykin, A. J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg4122 · Cited by 64 · see citing works
Gyengési, E., Rangel, A., Ullah, F., Liang, H., Niedermayer, G., Asgarov, R., Venigalla, M., Gunawardena, D., Karl, T., & Münch, G. W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00303 · Cited by 63 · see citing works
HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture
Hu, G., Niu, F., Liao, K., Periyasamy, P., Sil, S., Liu, J., Dravid, S. M., & Buch, S. J. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09869-8 · Cited by 63 · see citing works
Defining the Teratoma as a Model for Multi-lineage Human Development
McDonald, D., Wu, Y., Dailamy, A., Tat, J., Parekh, U., Zhao, D., Hu, M. Y., Tipps, A. M. P., Zhang, K., & Mali, P. (2020) · Cell · doi:10.1016/j.cell.2020.10.018 · Cited by 58 · see citing works
Ca2+-triggered synaptic vesicle fusion initiated by release of inhibition
Brunger, A., Leitz, J., Zhou, Q.-J., Choi, U. B., & Lai, Y. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.004 · Cited by 51 · see citing works
Xu, C., Tian, G.-A., Jiang, C., Xue, H., Kuerbanjiang, M., Sun, L., Gu, L., Zhou, H., Liu, Y., Zhang, Z., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1467-7 · Cited by 58 · see citing works
Fluid biomarkers in Alzheimer's disease
Simrén, J., Elmgren, A., Blennow, K., & Zetterberg, H. (2023) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2022.09.006 · Cited by 58 · see citing works
Singer, R. A., Arnes, L., Cui, Y., Wang, J., Gao, Y., Guney, M. A., Burnum-Johnson, K., Rabadán, R., Ansong, C. K., Orr, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.013 · Cited by 57 · see citing works
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia
van der Ende, E. L., Bron, E. E., Poos, J. M., Jiskoot, L. C., Panman, J. L., Papma, J. M., Meeter, L. H. H., Dopper, E. G. P., Wilke, C., Synofzik, M., et al. (2021) · Brain · doi:10.1093/brain/awab382 · Cited by 56 · see citing works
Harada, Y., Yamada, M., Imayoshi, I., Kageyama, R., Suzuki, Y., Kuniya, T., Furutachi, S., Kawaguchi, D., & Gotoh, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-26605-0 · Cited by 56 · see citing works
Nilsson, J., Constantinescu, J., Nellgård, B., Jakobsson, P., Brum, W. S., Gobom, J., Forsgren, L., Dalla, K., Constantinescu, R., Zetterberg, H., et al. (2022) · Movement Disorders · doi:10.1002/mds.29287 · Cited by 56 · see citing works
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Hruška-Plocháň, M., Wiersma, V. I., Betz, K. M., Mallona, I., Ronchi, S., Maniecka, Z., Hock, E., Tantardini, E., Laferrière, F., Sahadevan, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07042-7 · Cited by 72 · see citing works
Invasive Insects: Management Methods Explored
McLaughlin, G. M., & Dearden, P. K. (2019) · Journal of Insect Science · doi:10.1093/jisesa/iez085 · Cited by 58 · see citing works
Structural basis for the tryptophan sensitivity of TnaC-mediated ribosome stalling
van der Stel, A., Gordon, E. R., Sengupta, A., Martínez, A. K., Klepacki, D., Perry, T. N., del Valle, A. H., Vázquez‐Laslop, N., Sachs, M. S., Cruz-Vera, L. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25663-8 · Cited by 55 · see citing works
Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging
Ryan, L., Hay, M., Huentelman, M. J., Duarte, A., Rundek, T., Levin, B. E., Soldan, A., Pettigrew, C. A., Mehl, M. R., & Barnes, C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00128 · Cited by 54 · see citing works
Moreno‐Rodríguez, M., Perez, S. E., Nadeem, M., Malek‐Ahmadi, M. H., & Mufson, E. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1723-x · Cited by 52 · see citing works
Lang, Y., Li, Y., Yu, H., Lin, L., Chen, X., Wang, S., & Zhang, H. (2020) · Aging · doi:10.18632/aging.103028 · Cited by 50 · see citing works
Soldan, A., Oh, S., Ryu, T., Pettigrew, C. A., Zhu, Y., Moghekar, A., Xiao, M., Pontone, G. M., Albert, M., Na, C. H., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26725 · Cited by 49 · see citing works
Self-citationXie, H., Heier, C., Kien, B., Vesely, P. W., Tang, Z., Sexl, V., Schoiswohl, G., Strießnig-Bina, I., Höefler, G., Zechner, R., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158737 · Cited by 48 · see citing works
The Role of Neuronal Pentraxin 2 (NP2) in Regulating Glutamatergic Signaling and Neuropathology
Chapman, G., Shanmugalingam, U., & Smith, P. D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00575 · Cited by 48 · see citing works
Ma, Q., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M. R., Denver, P., Castro, D., Gu, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558036 · Cited by 48 · see citing works
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function
Xiao, M.-F., Roh, S., Zhou, J., Chien, D. C.-C., Lucey, B. P., Craig, M. T., Hayes, L. N., Coughlin, J. M., Leweke, F. M., Jia, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6935 · Cited by 48 · see citing works
Self-citationPrecision Medicine and cardiac channelopathies: when dreams meet reality
Gnecchi, M., Sala, L., & Schwartz, P. J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab007 · Cited by 44 · see citing works
Spatiotemporal transcriptomic maps of mouse intracerebral hemorrhage at single-cell resolution
Xiang, R., Wang, J., Chen, Z., Tao, J. Z., Peng, Q., Ding, R., Zhou, T., Tu, Z., Yang, T., Yang, T., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.026 · Cited by 48 · see citing works
LEAFY activity is post‐transcriptionally regulated by BLADE ON PETIOLE 2 and CULLIN 3 in Arabidopsis
Chahtane, H., Zhang, B., Norberg, M., Masson, M. L., Thévenon, E., Bakó, L., Benlloch, R., Holmlund, M., Parcy, F., Nilsson, O. R., et al. (2018) · New Phytologist · doi:10.1111/nph.15329 · Cited by 46 · see citing works
Soldan, A., Moghekar, A., Walker, K. A., Pettigrew, C. A., Hou, X., Lu, H., Miller, M. I., Alfini, A. J., Albert, M., Xu, D., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00132 · Cited by 46 · see citing works
Self-citationCysteine oxidation and disulfide formation in the ribosomal exit tunnel
Schulte, L., Mao, J., Reitz, J., Sreeramulu, S., Kudlinzki, D., Hodirnau, V.-V., Meier‐Credo, J., Saxena, K., Buhr, F., Langer, J. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19372-x · Cited by 46 · see citing works
Katsuki, F., Gerashchenko, D., & Brown, R. E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.002 · Cited by 52 · see citing works
Data-Driven vs Consensus Diagnosis of MCI
Edmonds, E. C., Smirnov, D. S., Thomas, K. R., Graves, L. V., Bangen, K. J., Delano‐Wood, L., Galasko, D. R., Salmon, D. P., & Bondi, M. W. (2021) · Neurology · doi:10.1212/wnl.0000000000012600 · Cited by 44 · see citing works
Self-citationAPOE 𝜀4‐related blood–brain barrier breakdown is associated with microstructural abnormalities
Reas, E. T., Solders, S. K., Tsiknia, A. A., Triebswetter, C., Shen, Q., Rivera, C. S., Andrews, M., Alderson‐Myers, A., & Brewer, J. B. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14302 · Cited by 44 · see citing works
Self-citationKovács, R. Á., Vadászi, H., Bulyáki, É., Török, G., Tóth, V., Mátyás, D., Kun, J., Hunyadi-Gulyás, É., Fedor, F. Z., Csincsi, Á., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599771 · Cited by 43 · see citing works
Higginbotham, L. A., Carter, E. K., Dammer, E. B., Haque, R. U., Johnson, E. C. B., Duong, D. M., Yin, L., Jager, P. L. D., Bennett, D. A., Felsky, D., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106286 · Cited by 44 · see citing works
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Liu, H., Luo, K., & Luo, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-21256-6 · Cited by 42 · see citing works
Boiten, W., van Steenoven, I., Xiao, M.-F., Worley, P., Noli, B., Cocco, C., Ferri, G.-L., Lemstra, A., & Teunissen, C. (2020) · Cells · doi:10.3390/cells10010038 · Cited by 42 · see citing works
Self-citationDendritic processing of spontaneous neuronal sequences for single-trial learning
Haga, T., & Fukai, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-33513-9 · Cited by 43 · see citing works
Tang, C., Zhang, D., Yang, J., Liu, Q.-H., Wang, Y., & Wang, W. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1522-4 · Cited by 41 · see citing works
Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100176 · Cited by 41 · see citing works
Belbin, O., Xiao, M.-F., Xu, D., Carmona-Iragui, M., Pegueroles, J., Benejam, B., Videla, L., Fernández, S., Barroeta, I., Nuñez-Llaves, R., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00398-0 · Cited by 39 · see citing works
Self-citationLista, S., Santos‐Lozano, A., Emanuele, E., Mercuri, N. B., Gabelle, A., López‐Ortiz, S., Martín-Hernández, J., Maisto, N., Imbimbo, C., Caraci, F., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02376-6 · Cited by 42 · see citing works
Structure of Myosin VI/Tom1 complex reveals a cargo recognition mode of Myosin VI for tethering
Hu, S., Guo, Y., Wang, Y., Li, Y., Fu, T., Zhou, Z., Wang, Y., Liu, J., & Pan, L. (2019) · Nature Communications · doi:10.1038/s41467-019-11481-6 · Cited by 40 · see citing works
Innate Immune Regulation Under Magnetic Fields With Possible Mechanisms and Therapeutic Applications
Lei, H., Pan, Y., Wu, R., & Lv, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582772 · Cited by 40 · see citing works
- Authors
- Xiao, M.-F., Xu, D., Craig, M. T., Pelkey, K. A., Chien, C.-C., Shi, Y., Zhang, J., Resnick, S., Pletnikova, O., Salmon, D., Brewer, J., Edland, S., Wegiel, J., Tycko, B., Savonenko, A., Reeves, R. H., Troncoso, J. C., McBain, C. J., Galasko, D., & Worley, P. F.
- Affiliations
- Johns Hopkins University (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- National Institute on Aging (US)
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, United States
- University of California San Diego (US)
- Institute for Basic Research, New York City, United States
- Columbia University (US)
- Corresponding author
- Worley, Paul F
- ORCID
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2017-03-23
- Volume
- 6
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC5404919
- OpenAlex
- W2606988847
- Cited by
- 316
- References
- 91
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 43 · 2023: 28 · 2022: 27 · 2021: 49 · 2020: 49 · 2019: 37 · 2018: 18 · 2017: 4
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Open Research Exeter (University of Exeter) (submittedVersion, cc-by)
- Funders
- LuMind Research Down Syndrome Foundation
- National Institute on Aging (AG05131)
- National Institute of Mental Health (P50 AG005146-27, MH100024, R35 NS-097966)
- Alzheimer’s drug discovery foundation (20021106)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- NPTX2, Alzheimer's disease, cognitive impairment, GluA4, AMPA receptors, parvalbumin interneurons, fast-spiking interneurons, pyramidal neurons, hippocampus, cortical excitability, neural oscillations, amyloidosis, memory loss, cerebrospinal fluid biomarkers, hippocampal volume, synaptogenesis
- MeSH terms
- Pentraxins, Alzheimer Disease, Animals, C-Reactive Protein, Cerebral Cortex, Disease Models, Animal, Hippocampus, Humans, Nerve Tissue Proteins, Mice, Knockout, Mice, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
